Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
D003622:Dapsone / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004893:Erythema Nodosum / Q000188:drug therapy; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D009443:Neuritis / Q000188:drug therapy; D010619:Phenazines / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy
D010619:Phenazines; D003622:Dapsone